Global Markets for In Vitro Toxicity Testing
June 27, 2011
Wellesley, Mass. – In a recent release, GLOBAL MARKETS FOR IN VITRO TOXICITY TESTING (PHM017D) from BCC Research (www.bccresearch.com), the global market value for in vitro toxicity testing was $1.3 billion in 2010. That value is anticipated to reach $2.7 billion in 2015 as it increases at a five-year compound annual growth rate (CAGR) of 15.4%.
The global in vitro toxicology market can be broken down into four segments – cosmetic and household, pharmaceuticals, chemicals, and food additives.
The cosmetic and household segment was worth $702 million in 2010, and in 2015 should be worth $1.3 billion, yielding a CAGR of 13.1%.
The pharmaceuticals segment, worth $424 million in 2010, should rise in 2015 to $976 million at a CAGR of 18.2%.
The chemicals segment was worth $159 million in 2010, and in 2015 is expected to be worth $353 million, a CAGR of 17.3%.
The food additives segment was worth $40 million in 2010, and in 2015 should be worth $81.3 million, a CAGR of 15.4%.
Toxicology is the study of the adverse effects of chemical, physical, or biological agents on living organisms or ecosystems, based on the principle that any substance can be toxic if consumed in sufficient quantity. Most developed countries have laws and regulations to control the marketing of drugs, vaccines, food additives, pesticides, industrial chemicals, and many other substances of potential toxicological concern.
The in vitro toxicity testing market is being driven by technological advancements as well as validations by regulatory authorities. Testing can be classified into two categories – mechanistic and nonmechanistic approaches. Statistical-based (nonmechanistic) approaches are expected to continue growing, as they are integrated into existing mechanistic measuring pathways.
The report is designed to inform a wide variety of individuals involved in the toxicity marketplace, primarily company senior management executives looking to make strategic decisions based on toxicology market forces and trends. The report is also aimed at helping managers and executives in product research and development, particularly those bringing new products to market.
Global Markets for In Vitro Toxicity Testing( PHM017D )
Publish Date: Sep 2010
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Pharmaceuticals
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
- Global GLP-1 Analogues Market to Reach $268.4 Billion by 2030
- AI in Clinical Trials Poised for Rapid Growth with a 22.6% CAGR Forecast
Reports from Pharmaceuticals
Recent News
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand